HY-13218-10mg
|
MedChemexpress LLC
|
Acitazanolast [CAS 114607-46-4]
|
|
COVID-19-immunoregulation
|
|
HY-13218-100mg
|
MedChemexpress LLC
|
Acitazanolast [CAS 114607-46-4]
|
|
COVID-19-immunoregulation
|
|
HY-13218-25mg
|
MedChemexpress LLC
|
Acitazanolast [CAS 114607-46-4]
|
|
COVID-19-immunoregulation
|
|
HY-13218-5mg
|
MedChemexpress LLC
|
Acitazanolast [CAS 114607-46-4]
|
|
COVID-19-immunoregulation
|
|
HY-13218-50mg
|
MedChemexpress LLC
|
Acitazanolast [CAS 114607-46-4]
|
|
COVID-19-immunoregulation
|
|
HY-P9949-1mg
|
MedChemexpress LLC
|
Reslizumab [CAS 241473-69-8]
|
|
COVID-19-immunoregulation
|
|
HY-P9949-2mg
|
MedChemexpress LLC
|
Reslizumab [CAS 241473-69-8]
|
|
COVID-19-immunoregulation
|
|
HY-13218-1mL
|
MedChemexpress LLC
|
Acitazanolast [CAS 114607-46-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-P1240B-1mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
HY-P1240B-10mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
HY-P1240B-5mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|